Christopher Richard Anzalone is Chief Executive Officer at Arrowhead Pharmaceuticals. OQRO lists 30 transactions filed with the SEC under this name, the latest on Jan 6, 2026, each linked to the official Form 4.
Chief Executive Officer
Disclosures on record
30
Companies involved
1
Arrowhead PharmaceuticalsARWR
30 disclosures · Dec 2025 – Jan 2026 · 25 sold
Jan 2, 2026Sold~$489Kdisclosed Jan 6
DetailsOfficial recordJan 2, 2026Sold~$383Kdisclosed Jan 6
DetailsOfficial recordDec 29, 2025Sold~$2.44Mdisclosed Dec 30
DetailsOfficial recordDec 29, 2025Sold~$1.14Mdisclosed Dec 30
DetailsOfficial recordDec 29, 202517Kdisclosed Dec 30
DetailsOfficial recordDec 29, 202535Kdisclosed Dec 30
DetailsOfficial recordDec 29, 202535Kdisclosed Dec 30
DetailsOfficial recordDec 29, 202517Kdisclosed Dec 30
DetailsOfficial recordDec 22, 2025Sold~$684Kdisclosed Dec 23
DetailsOfficial recordDec 19, 2025Sold~$554Kdisclosed Dec 23
DetailsOfficial recordDec 19, 2025Sold~$265Kdisclosed Dec 23
DetailsOfficial recordDec 22, 2025Sold~$177Kdisclosed Dec 23
DetailsOfficial recordDec 19, 2025Sold~$90Kdisclosed Dec 23
DetailsOfficial recordDec 17, 2025Sold~$2.94Mdisclosed Dec 19
DetailsOfficial recordDec 17, 2025Sold~$2.31Mdisclosed Dec 19
DetailsOfficial recordDec 17, 2025Sold~$131Kdisclosed Dec 19
DetailsOfficial recordDec 17, 2025Sold~$64Kdisclosed Dec 19
DetailsOfficial recordDec 15, 2025Sold~$6.9Mdisclosed Dec 16
DetailsOfficial recordDec 15, 2025Sold~$1.48Mdisclosed Dec 16
DetailsOfficial recordDec 16, 2025Sold~$876K
DetailsOfficial recordDec 16, 2025Sold~$671K
DetailsOfficial recordDec 15, 2025Sold~$570Kdisclosed Dec 16
DetailsOfficial recordDec 16, 2025Sold~$533K
DetailsOfficial recordDec 16, 2025Sold~$509K
DetailsOfficial recordDec 16, 2025Sold~$428K
DetailsOfficial recordDec 16, 2025Sold~$219K
DetailsOfficial recordDec 16, 2025Sold~$86K
DetailsOfficial recordDec 16, 2025Sold~$65K
DetailsOfficial recordDec 16, 2025Sold~$11K
DetailsOfficial recordDec 12, 2025180Kdisclosed Dec 16
DetailsOfficial record